ㆍ법령자료

ㆍ작성자 ㆍ작성일 2020-05-19 (화) 15:27 ㆍ첨부#1 EMA_CHMP_BWP_457920_2012_rev_1.pdf (130KB) (Down:4009) ㆍ조회: 2572   [바이러스 불활화] EMA_CHMP/BWP/457920/2012Rev.1 Title : Use of bovine serum in the manufacture of human biological medicinal products Reference number : CHMP/BWP/457920/2012 Rev. 1 Description : This document outlines the general principles that should be applied to the control of the quality and safety of bovine serum used during the manufacture of human biological medicinal products. It applies to vaccines and biotechnological products. It also covers dossier requirements for marketing authorisation applications/variations. Source : EMA Homepage (https://www.ema.europa.eu/en)